Laboratorios LETI SL:企業の戦略的SWOT分析

◆英語タイトル:Laboratorios LETI SL - Strategic SWOT Analysis Review
◆商品コード:DATA904C15909
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Laboratorios LETI SL – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Laboratorios LETI SL (LETI) is biopharmaceutical research company that offers products for early diagnosis, disease prevention and specialized body care. The company’s products include allergen extracts for the diagnosis and treatment of allergy; dermopharmaceutical products and other specialty products for personal care; and solutions for the prevention, diagnosis and treatment of primary immune diseases of companion animals, including allergy and leishmaniasis. It has production facility and allergy research laboratory in Tres Cantos, Spain. The company operates through its subsidiaries in Germany and Portugal; and a network of distributors across Europe, Latin America and Africa. LETI is headquartered in Barcelona, Spain.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Laboratorios LETI SL – Key Facts
Laboratorios LETI SL – Key Employees
Laboratorios LETI SL – Major Products and Services
Laboratorios LETI SL – History
Laboratorios LETI SL – Company Statement
Laboratorios LETI SL – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Laboratorios LETI SL – Business Description
Laboratorios LETI SL – SWOT Analysis
SWOT Analysis – Overview
Laboratorios LETI SL – Strengths
Laboratorios LETI SL – Weaknesses
Laboratorios LETI SL – Opportunities
Laboratorios LETI SL – Threats
Laboratorios LETI SL – Key Competitors
Section 3 – Company’s, Lifesciences Financial Deals and Alliances
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Laboratorios LETI SL, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Laboratorios LETI SL, Key Facts
Laboratorios LETI SL, Key Employees
Laboratorios LETI SL, Major Products and Services
Laboratorios LETI SL, History
Laboratorios LETI SL, Other Locations
Laboratorios LETI SL, Subsidiaries
Laboratorios LETI SL, Key Competitors
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Laboratorios LETI SL, Recent Deals Summary

List of Figures
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Laboratorios LETI SL, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Laboratorios LETI SL:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mersen SA (MRN):企業のM&A・提携動向(エネルギー分野)
    Summary Mersen SA (Mersen), formerly, Groupe Carbone Lorraine SA is a manufacturer of electrical specialties and graphite based materials. The company’s product portfolio comprises solutions such as carbon products, graphite products and electrical components for high temperature conditions besides …
  • Laboratory Corp of America Holdings (LH):医療機器:M&Aディール及び事業提携情報
    Summary Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics la …
  • Amaru, Inc. (AMRU):企業の財務及び戦略的SWOT分析
    Summary Amaru, Inc. (Amaru) is Telecommunication Company that is in the business of broadbands entertainment. The company on demand streams via computers, television sets, PDAs (Personal Digital Assistant) and 3G hand phone. It offers services such as advertising and channel sponsorship, online subs …
  • Medy-Tox Inc. (086900)(製薬・医療分野):企業M&A動向
    Summary Medy-tox Inc. (Medy-tox) is a biotechnology company. The company manufactures botulinum toxin biopharmaceuticals. Its product segments include botulinium toxin, hyaluronic acid filler, medcial devices, and toxin detection and antitoxin therapeutics. Medy-tox’s products include Neuronox 50U, …
  • Cypress Energy Partners LP (CELP):石油・ガス:M&Aディール及び事業提携情報
    Summary Cypress Energy Partners LP (Cypress Energy), a subsidiary of Cypress Energy Holdings LLC, is an energy services company that provides midstream services. The company provides services such as pipeline inspection, integrity and hydrostatic testing services to energy, exploration and productio …
  • Harsco Corporation:企業の戦略・SWOT・財務分析
    SummaryHarsco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • GreenPeptide Co Ltd (4594):企業財務及び戦略的SWOT分析
    Summary GreenPeptide Co Ltd (GreenPeptide) is a clinical-stage biopharmaceutical company that develops novel cancer immunotherapies. The company operates on drug discovery research and early clinical development of cancer immunotherapy; conducting of early-phase clinical trials; and development, man …
  • Awilco LNG AS (ALNG):企業概要、財務及び戦略的SWOT分析
    Summary Awilco LNG AS (Awilco LNG) is an oil and gas company. It offers LNG transportation. It owns and operates LNG vessels focused on international trade. The company’s primary product is Liquefied Natural Gas (LNG). The company’s LNG value chain includes production, liquefaction, transportation, …
  • Health Management International Ltd. (588):企業の財務及び戦略的SWOT分析
    Summary Health Management International Ltd (HMI) is a pharmaceutical company that offers healthcare service. The company’s businesses include regency specialist hospital, mahkota medical centre, and HMI institute of health sciences. Its regency specialist hospital provides medical and surgical spec …
  • Fugro NVの企業概要及び財務/SWOT分析
    Fugro NV Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts ma …
  • ViaCord LLC:企業の戦略的SWOT分析
    ViaCord LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Vijaya Bank:企業の戦略・SWOT・財務情報
    Vijaya Bank - Strategy, SWOT and Corporate Finance Report Summary Vijaya Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hydra Biosciences, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hydra Biosciences, Inc. Mergers …
  • Unchained Labs-製薬・医療分野:企業M&A・提携分析
    Summary Unchained Labs is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparation system), …
  • Aero Components Inc.:企業の戦略・SWOT・財務情報
    Aero Components Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero Components Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • DFDS A/S:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DFDS A/S Mergers and Acquisitio …
  • Bayer HealthCare AG – Product Pipeline Analysis, 2016 Update
    Summary Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group, is a healthcare company. It designs, researches, develops, manufactures and sells pharmaceuticals and consumer health products. The company provides prescription pharmaceuticals, such as anticoagulants; treatments for can …
  • Autolus Therapeutics Plc (AUTL):製薬・医療:M&Aディール及び事業提携情報
    Summary Autolus Therapeutics Plc (Autolus), formerly Autolus Therapeutics Limited is a clinical-stage biopharmaceutical company which offers programmed T cell immunotherapies for the treatment of hematological cancers and solid tumors. The company utilizes its T-cell programming and manufacturing te …
  • Le Noble Age S.A. (LNA):企業の財務及び戦略的SWOT分析
    Summary Le Noble Age S.A. (Le Noble Age) is a healthcare service provider that includes elderly care services. The company offers care facilities for the elderly and disabled residents. It provides medical activities, in care institutions and rehabilitation, and support services. Le Noble Age runs r …
  • Omega Pharma NV:企業のM&A・事業提携・投資動向
    Omega Pharma NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Omega Pharma NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆